Janus Henderson Group PLC Dyne Therapeutics, Inc. Call Options Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DYN
# of Institutions
218Shares Held
116MCall Options Held
322KPut Options Held
66.2K-
Ra Capital Management, L.P. Boston, MA9.71MShares$96.7 Million2.11% of portfolio
-
Atlas Venture Life Science Advisors, LLC9.13MShares$90.8 Million27.97% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.41MShares$73.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$73.5 Million0.01% of portfolio
-
Fcpm Iii Services B.V. Naarden, P75.46MShares$54.4 Million13.81% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $515M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...